# US 6,727,068 B2 · Method for non-redundant library construction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,068 B2
- Document ID: US6727068B2
- Status: Granted
- Kind: B2
- Application number: 10/055,109
- Filed: 2002-01-23
- Published: 2003-01-30
- Granted: 2004-04-27
- Earliest claimed: 2001-01-24
- Assignees: Syngenta Participations AG
- Inventors: Liang Shi; Xun Wang; Bi-Yu Li
- Web page: https://patentgrep.com/patent/US6727068B2

## CPC

- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6855: Ligating adaptors
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided are novel methods for the production of nucleic acid libraries having reduced redundancy. Also provided are methods for determination of changes in RNA expression associated with pathological conditions, and physiological or developmental state. Additional aspects provided non-redundant tags or probes produced by the disclosed methods and microarrays incorporating such tags.

## Claims

### Claim 1

A method for constructing a nucleic acid library comprising:
a) obtaining a population of end-labeled double-stranded cDNA molecules;
b) dividing said population into a first portion and a second portion;
c) digesting said first portion with at least one sequence-specific endonuclease wherein said first portion is divided into one pool per endonuclease;
d) digesting said second portion with at least one (Y) endonuclease having a degenerate recognition sequence and fractionating the digested cDNA into YXz pools where Y is the number of degenerate endonucleases, X is the the extent of degeneracy and z is the number of bases;
e) isolating nucleic acid fragments from said endonuclease digestions of said first and second portions using said end-labels;
f) digesting the fragments of said first portion with said at least one endonuclease of d) sequence and fractionating the digested cDNA into YXz pools where Y is the number of degenerate endonucleases, X is the the extent of degeneracy and z is the number of bases;
g) digesting the fragments of said second portion with said at least one endonuclease of c) wherein the second portion pools are divided into one pool per endonuclease;
h) removing labeled nucleic acid fragments from said first and second portions while retaining unlabeled fragments;
i) adding a population of adapters to each of the pools, said population containing adapters specific for the endonucleases used, wherein each adapter comprises a first region specific to a particular endonuclease used and a second region containing a primer binding site;
j) hybridizing and ligating said adapters to said unlabeled fragments;
k) amplifying the fragments using the adapters; and
l) separating the amplified fragments by size.

### Claim 2 (depends on 1)

The method of claim 1, wherein said at least one sequence-specific endonuclease comprises at least 4 different sequence specific endonucleases.

### Claim 3 (depends on 1)

The method of claim 1, wherein said at least one sequence-specific endonuclease comprises at least 6 different sequence specific endonucleases.

### Claim 4 (depends on 1)

The method of claim 1, wherein said at least one sequence-specific endonuclease is selected from the group consisting of at least one endonuclease having a 4 base recognition sequence, at least one endonuclease having a 5 base recognition sequence and at least one endonuclease having a 6 base recognition sequence.

### Claim 5 (depends on 3)

The method of claim 3, wherein said at least one sequence-specific endonuclease is selected from the group consisting of Apa LI, Bam HI, Eco RI, Hind III, Nco I, and Xho I.

### Claim 6 (depends on 1)

The method of claim 1, wherein said at least one endonuclease having a degenerate recognition sequence produces fragments comprising unpaired overhangs containing Nm unique sequences where N is the extent of degeneracy and is an integer between 2 and 4, and m is the number of bases in said unpaired overhang and is an integer between 2 and 6.

### Claim 7 (depends on 6)

The method of claim 6, wherein Nm equals at least 64.

### Claim 8 (depends on 7)

The method of claim 7 wherein said endonuclease is Bsl I.

### Claim 9 (depends on 1)

The method of claim 1, further comprising sequencing the separated fragments of I).

### Claim 10 (depends on 1)

The method of claim 1, further comprising quantifying the separated fragments of I).

### Claim 11 (depends on 1)

The method of claim 1, wherein said primer binding region of said adapters does not have significant homology to sequences known to be in said population of nucleic acid molecules.

### Claim 12 (depends on 11)

The method of claim 11, wherein said primer binding regions of said adapters comprise no more than 10 different sequences.

### Claim 13 (depends on 12)

The method of claim 12, wherein said primer binding region comprise no more than two different sequences.

### Claim 14 (depends on 1)

The method of claim 1, wherein said end-labeled nucleic acid molecules are obtained by a method comprising, isolating polyA mRNA from a cell; hybridizing a 5′ end labeled an oligo dT primer to said polyA mRNA; synthesizing a first cDNA strand by extension of said primer; and synthesizing a second cDNA strand by nick translation to produce double stranded cDNA.

### Claim 15 (depends on 14)

The method of claim 14, wherein said oligo dT primer has a sequence comprising L-(T)nVN, where L is a label at the 5′ end of said primer and n is an integer between 4 and 50.

### Claim 16 (depends on 14)

The method of claim 14, wherein said at least one sequence-specific endonuclease comprises at least 4 different endonucleases.

### Claim 17 (depends on 14)

The method of claim 14, wherein said at least one sequence-specific endonuclease is selected from the group consisting of at least one endonuclease having a 4 base recognition sequence, at least one endonuclease having a 5 base recognition sequence and at least one endonuclease having a six base recognition sequence.

### Claim 18 (depends on 14)

The method of claim 14, wherein said at least one sequence-specific endonuclease comprises at least 6 different endonucleases.

### Claim 19 (depends on 18)

The method of claim 18, wherein said at least one sequence-specific endonuclease is selected from the group consisting of Apa LI, Bam HI, Eco RI, Hind III, Nco I, and Xho I.

### Claim 20 (depends on 14)

The method of claim 14, wherein said at least one endonuclease having a degenerate recognition sequence produces fragments comprising unpaired overhangs containing Nm unique sequences where N is the extent of degeneracy and is an integer between 2 and 4, and m is the number of bases in said unpaired overhang and is an integer between 2 and 6.

### Claim 21 (depends on 20)

The method of claim 20, wherein Nm equals at least 64.

### Claim 22 (depends on 21)

The method of claim 21 wherein said endonuclease is Bsl I.

### Claim 23 (depends on 14)

The method of claim 14, wherein said label is biotin.

### Claim 24 (depends on 14)

The method of claim 14, wherein isolating and removing of end-labeled nucleic acid molecules is by particles that bind said end-labeled nucleic acid molecules.

### Claim 25 (depends on 24)

The method of claim 24, wherein said end-label is biotin and said particles comprise avidin or strepavidin.

### Claim 26 (depends on 14)

The method of claim 14, further comprising sequencing the separated fragments of I).

### Claim 27 (depends on 14)

The method of claim 14, further comprising quantifying the separated fragments of I).

### Claim 28

A method for constructing a nucleic acid library comprising:
a) obtaining a population of 3′ end-labeled double-stranded cDNA molecules by a method comprising, isolating polyA mRNA from a cell; hybridizing a 5′ end labeled primer containing an oligo dT tail to said polyA mRNA; synthesizing a first cDNA strand by extension of said primer; and synthesizing a second cDNA strand by nick translation to produce a double stranded cDNA;
b) dividing said labeled population into a first portion and a second portion;
c) digesting said first portion with at least one sequence-specific endonuclease selected from the group consisting of at least one endonuclease having a 4 base recognition sequence, at least one endonuclease having a 5 base recognition sequence and at least one endonuclease having a six base recognition sequence wherein said first portion is divided into one pool per endonuclease;
d) digesting said second portion with at least one endonuclease having a degenerate recognition sequence wherein said endonuclease produces fragments comprising unpaired overhangs containing Nm unique sequences where N is an integer between 2 and 4, m is an integer between 2 and 6, and Nm equals at least 64 and fractionating the digested cDNA into YXz pools where Y is the number of degenerate endonucleases, X is the extent of degeneracy and z is the number of bases;
e) isolating nucleic acid fragments from said endonuclease digestions of said first and second portions using said end-labels;
f) digesting the fragments of said first portion with said at least one endonuclease of d) and fractionating the digested cDNA into YXz pools where Y is the number of degenerate endonucleases, X is the extent of degeneracy and z is the number of bases;
g) digesting the fragments of said second portion with said at least one endonuclease of c) wherein said first portion is divided into one pool per endonuclease;
h) removing labeled nucleic acid fragments from said first and second portions while retaining unlabeled fragments;
i) adding a population of adapters to each of the pools, said population containing adapters specific for at least some of the endonucleases used, wherein each adapter comprises a first region specific to a particular endonuclease used and a second region containing a primer binding site, said primer binding sites comprising no more than 10 different sequences, said sequences lacking significant homology to sequences known to be in said population of nucleic acid molecules;
j) hybridizing and ligating said adapters to said unlabeled fragments;
k) amplifying said unlabeled fragments using the adapters; and
l) separating the amplified fragments on the basis of size.

### Claim 29 (depends on 28)

The method of claim 28, wherein said at least one sequence-specific endonuclease comprises at least 4 endonucleases.

### Claim 30 (depends on 28)

The method of claim 28, wherein said at least one sequence-specific endonuclease comprises at least 6 endonucleases.

### Claim 31 (depends on 30)

The method of claim 30, wherein said at least one sequence-specific endonuclease is selected from the group consisting of Apa LI, Bam HI, Eco RI, Hind III, Nco I, and Xho I.

### Claim 32 (depends on 28)

The method of claim 28, wherein said at least one endonuclease having a degenerate recognition sequence is Bsl I.

### Claim 33 (depends on 28)

The method of claim 28, wherein said at least one sequence-specific endonuclease is selected from the group consisting of Apa LI, Bam HI, Eco RI, Hind III, Nco I, and Xho I, and said at least one endonuclease having a degenerate recognition sequence is Bsl I.

### Claim 34 (depends on 28)

The method of claim 28, wherein said adapters comprise a common primer binding site.

### Claim 35 (depends on 28)

The method of claim 28, further comprising sequencing the separated fragments of 1).

### Claim 36 (depends on 28)

The method of claim 28, further comprising quantifying the separated fragments of I).

### Claim 37 (depends on 28)

The method of claim 28, wherein said label is biotin.

### Claim 38 (depends on 28)

The method of claim 28, wherein isolating and removing of end-labeled nucleic acid molecules is by particles that bind said end-labeled nucleic acid molecules.

### Claim 39 (depends on 38)

The method of claim 38, wherein said end-label is biotin and said particles comprise avidin or strepavidin.

### Claim 40

A method for constructing a nucleic acid library comprising:
a) obtaining a population of double stranded cDNA wherein cDNA molecules contained in said population contain a detectable label on their 3′ end;
b) digesting said double-stranded cDNA with at least one restriction endonuclease having a degenerate recognition sequence comprising at least one degenerate base, wherein said digestion creates a single-stranded portion or overhang containing a region having the formula Nm, where N is the extent of degeneracy and m is the number of degenerate bases in said single stranded portion or overhang to produce digestion fragments and fractionating the digested cDNA into YXz pools where Y is the number of degenerate endonucleases, X is the extent of degeneracy and z is the number of bases;
c) adding a population of adapters to each of the pools, said adapters specific for the at least one endonuclease used;
d) hybridizing and ligating said adapters to the 5′ end of said digestions fragments;
e) separating said 3′ end digestion fragments using said detectable label;
f) amplifying said 3′ end digestion fragments;
g) separating said amplified digestion fragments on the basis of size.

### Claim 41 (depends on 40)

The method of claim 40, wherein said adapters contain first region specific to a particular endonuclease and a second primer binding region common to all adapters.

### Claim 42 (depends on 40)

The method of claim 40, wherein Nm equals at least 16.

### Claim 43 (depends on 42)

The method of claim 42, wherein said at least one endonuclease is BsaJ I.
